NCT00519818View on ClinicalTrials.gov

Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Congenital Adrenal Hyperplasia21-Hydroxylase DeficiencyAdrenogenital Syndrome
Interventions
DRUG

Chronocort

Chronocort 30 mg once daily nigh time dose for 28 +/- 3 days duration

DRUG

Cortef

Cortef 3 times daily(total dose 30 mg)for minimum of 7 days

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
collaborator

National Institutes of Health Clinical Center (CC)

NIH

lead

Neurocrine UK Limited

INDUSTRY

NCT00519818 - Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia | Biotech Hunter | Biotech Hunter